Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning

计划入组 58 人 · 首次发布于 2014 年 12 月 4 日

SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms

计划入组 40 人 · 首次发布于 2015 年 8 月 19 日

Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

计划入组 7 人 · 首次发布于 2017 年 2 月 13 日

TLR modulators (Idera)

SYN 001 (Avidea Technologies)

Cucurbita pepo subsp. ovifera whole

VIDELA SEBASTIAN

Argentina

Verdera Energy Corp

United States

VIVERA PHARMACEUTICALS, INC.

United States

Thermo Fisher Scientific Partners with Datavant to Enhance Real-World Data Connectivity in Clinical Research

Elicera Therapeutics Faces U.S. Patent Setback for iTANK CAR-T Enhancement Platform

Elicera Therapeutics Completes Patient Recruitment for ELC-100 Phase I/II Study